Dare Bioscience Inc (DARE)
0.43
0.00 (0.00%)
USD |
NASDAQ |
Jun 18, 16:00
0.4308
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Revenue (Quarterly): 0.0093M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0093M |
| December 31, 2023 | 1.808M |
| September 30, 2023 | 1.00M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 10.00M |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.033M |
| March 31, 2014 | 0.047M |
| December 31, 2013 | 0.006M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0093M
Minimum
Mar 2024
10.00M
Maximum
Jun 2022
3.204M
Average
1.404M
Median
Revenue (Quarterly) Benchmarks
| Altimmune Inc | 0.005M |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Orgenesis Inc | 0.141M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.755M |
| Total Expenses (Quarterly) | 6.032M |
| EPS Diluted (Quarterly) | -0.07 |
| Enterprise Value | 39.84M |
| Profit Margin (Quarterly) | -72.62K% |
| Earnings Yield | -74.42% |
| Normalized Earnings Yield | -74.42 |